You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Breast cancer

Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumours

  • Technology appraisal guidance
  • Reference number: TA265
  • Published:  24 October 2012
  • Guidance
  • Tools and resources
  • Information for the public
  • History

TA265 Bone metastases from solid tumours - denosumab: Appendix A provisional matrix of stakeholders

TA265 Bone metastases from solid tumours - denosumab: Appendix A provisional matrix of stakeholders TA265 Bone metastases from solid tumours - denosumab: Appendix A provisional matrix of stakeholders
29 July 2013
(104.47 Kb 30 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 26 July 2013

Back to top